Business Description
Faes Farma SA
ISIN : ES0134950F36
Total Employee Number:
1,894Compare
Compare
Traded in other countries / regions
FAE.Spain0K9H.UKFFEA.Germany IPO Date
2015-04-02Description
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 3.54 | |||||
Interest Coverage | 15.54 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.52 | |||||
Beneish M-Score | -2.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.8 | |||||
3-Year EBITDA Growth Rate | -0.9 | |||||
3-Year EPS without NRI Growth Rate | -4.3 | |||||
3-Year FCF Growth Rate | 27.2 | |||||
3-Year Book Growth Rate | 8.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 18.69 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.36 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 24.54 | |||||
9-Day RSI | 29.78 | |||||
14-Day RSI | 33.91 | |||||
3-1 Month Momentum % | -7.03 | |||||
6-1 Month Momentum % | -8.25 | |||||
12-1 Month Momentum % | -0.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.61 | |||||
Quick Ratio | 1.62 | |||||
Cash Ratio | 0.7 | |||||
Days Inventory | 271.61 | |||||
Days Sales Outstanding | 80.94 | |||||
Days Payable | 92.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.95 | |||||
Dividend Payout Ratio | 0.69 | |||||
3-Year Dividend Growth Rate | 37.4 | |||||
Forward Dividend Yield % | 2.95 | |||||
5-Year Yield-on-Cost % | 2.92 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | -13.73 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.86 | |||||
Operating Margin % | 14.92 | |||||
Net Margin % | 13.04 | |||||
EBITDA Margin % | 19.71 | |||||
FCF Margin % | 8.98 | |||||
OCF Margin % | 12.86 | |||||
ROE % | 10.86 | |||||
ROA % | 7.48 | |||||
ROIC % | 9.8 | |||||
3-Year ROIIC % | -1.06 | |||||
ROC (Joel Greenblatt) % | 18.4 | |||||
ROCE % | 10.06 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.1 | |||||
Forward PE Ratio | 13.89 | |||||
PE Ratio without NRI | 16.85 | |||||
Shiller PE Ratio | 16.12 | |||||
Price-to-Owner-Earnings | 36.89 | |||||
PEG Ratio | 4.68 | |||||
PS Ratio | 2.23 | |||||
PB Ratio | 1.81 | |||||
Price-to-Tangible-Book | 4.72 | |||||
Price-to-Free-Cash-Flow | 24.83 | |||||
Price-to-Operating-Cash-Flow | 17.31 | |||||
EV-to-EBIT | 18.07 | |||||
EV-to-EBITDA | 13.7 | |||||
EV-to-Revenue | 2.7 | |||||
EV-to-FCF | 30.32 | |||||
Price-to-GF-Value | 0.84 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-DCF (Earnings Based) | 0.97 | |||||
Price-to-DCF (FCF Based) | 0.72 | |||||
Price-to-Median-PS-Value | 0.78 | |||||
Price-to-Graham-Number | 1.88 | |||||
Earnings Yield (Greenblatt) % | 5.54 | |||||
FCF Yield % | 4.05 | |||||
Forward Rate of Return (Yacktman) % | 6.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Faes Farma SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 610.464 | ||
| EPS (TTM) (€) | 0.254 | ||
| Beta | 0.3902 | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 1 | ||
| Volatility % | 18.17 | ||
| 14-Day RSI | 33.91 | ||
| 14-Day ATR (€) | 0.080779 | ||
| 20-Day SMA (€) | 4.5205 | ||
| 12-1 Month Momentum % | -0.65 | ||
| 52-Week Range (€) | 4.1 - 5.44 | ||
| Shares Outstanding (Mil) | 311.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Faes Farma SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Faes Farma SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.087000 Cash Dividend | 2026-07-02 | 4.55 (-1.41%) | ||
| EUR 0.041000 Cash Dividend | 2026-01-08 | 5.38 (-1.10%) | ||
| EUR 0.138000 Cash Dividend | 2025-07-03 | 4.52 (-0.66%) | ||
| EUR 0.041000 Cash Dividend | 2025-01-09 | 3.51 (+0.29%) | ||
| 1.03846:1 Stock Split | 2023-04-12 | 3.11 (+0.47%) | ||
| 1.04:1 Stock Split | 2013-04-19 | 2.06 (+0.68%) | ||
| 2:1 Stock Split | 2007-01-29 | 13.54 (+0.34%) |
Show
Entries
Faes Farma SA Frequently Asked Questions
What is Faes Farma SA(XMAD:FAE)'s stock price today?
The current price of XMAD:FAE is €4.35. The 52 week high of XMAD:FAE is €5.44 and 52 week low is €4.10.
When is next earnings date of Faes Farma SA(XMAD:FAE)?
The next earnings date of Faes Farma SA(XMAD:FAE) is .
Does Faes Farma SA(XMAD:FAE) pay dividends? If so, how much?
The Dividend Yield %  of Faes Farma SA(XMAD:FAE) is 2.95% (As of Today), Highest Dividend Payout Ratio of Faes Farma SA(XMAD:FAE) was 0.76. The lowest was 0.24. And the median was 0.69. The  Forward Dividend Yield % of Faes Farma SA(XMAD:FAE) is 2.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Faes Farma SA
No articles.